Exact Mass: 415.151

Exact Mass Matches: 415.151

Found 50 metabolites which its exact mass value is equals to given mass value 415.151, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tenalisib

Tenalisib

C23H18FN5O2 (415.1444)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D000081082 - Phosphoinositide-3 Kinase Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

Idelalisib

5-fluoro-3-phenyl-2-{1-[(7H-purin-6-yl)amino]propyl}-3,4-dihydroquinazolin-4-one

C22H18FN7O (415.1557)


   

N-(1,2,3-trimethoxy-10-(methylthio)-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide

N-(1,2,3-trimethoxy-10-(methylthio)-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide

C22H25NO5S (415.1453)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Quetiapine Sulfone

Quetiapine Sulfone

C21H25N3O4S (415.1566)


   

N-Methyl-N-(3-[((N-tert-butoxycarbonyl-N-methylamino)acetoxy)methyl]pyridin-2-yl)carbamic acid 1-chloroethyl ester

N-Methyl-N-(3-[((N-tert-butoxycarbonyl-N-methylamino)acetoxy)methyl]pyridin-2-yl)carbamic acid 1-chloroethyl ester

C18H26ClN3O6 (415.151)


   

CAL-101

Idelalisib

C22H18FN7O (415.1557)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EM - Phosphatidylinositol-3-kinase (pi3k) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

7-Hydroxy Quetiapine S-Oxide

7-Hydroxy Quetiapine S-Oxide

C21H25N3O4S (415.1566)


   

Milenperone

Milenperone-d4

C22H23ClFN3O2 (415.1463)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

1,2:5,6-Di-O-isopropyliden-3-toluol-p-sulfonat-α-D-allofuranose-3-d

1,2:5,6-Di-O-isopropyliden-3-toluol-p-sulfonat-α-D-allofuranose-3-d

C19H25DO8S (415.1411)


   

Nivocasan

Nivocasan

C21H22FN3O5 (415.1543)


C471 - Enzyme Inhibitor

   

8-(2-Chloro-3,4,5-trimethoxy-benzyl)-9-pent-4-ylnyl-9H-purin-6-ylamine

8-(2-Chloro-3,4,5-trimethoxy-benzyl)-9-pent-4-ylnyl-9H-purin-6-ylamine

C20H22ClN5O3 (415.1411)


   

2-(2-methoxyphenyl)-N-[4-[5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide

2-(2-methoxyphenyl)-N-[4-[5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide

C24H21N3O4 (415.1532)


   

4-[2-[[1-(2-methoxyethyl)-2-benzimidazolyl]thio]-1-oxoethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester

4-[2-[[1-(2-methoxyethyl)-2-benzimidazolyl]thio]-1-oxoethyl]-2,5-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester

C21H25N3O4S (415.1566)


   

2-(2,4-dimethoxyphenyl)-N-[1-(2-furyl)ethylidene]-4-quinolinecarbohydrazide

2-(2,4-dimethoxyphenyl)-N-[1-(2-furyl)ethylidene]-4-quinolinecarbohydrazide

C24H21N3O4 (415.1532)


   

4-[(2,4-Dimethoxyanilino)methylidene]-2-(6-methyl-2-pyridinyl)isoquinoline-1,3-dione

4-[(2,4-Dimethoxyanilino)methylidene]-2-(6-methyl-2-pyridinyl)isoquinoline-1,3-dione

C24H21N3O4 (415.1532)


   

5-Carbamoyl-4-methyl-2-[[1-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester

5-Carbamoyl-4-methyl-2-[[1-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester

C21H25N3O4S (415.1566)


   

2-Methyl-1-phenyl-5-benzimidazolecarboxylic acid [2-(2-methoxyanilino)-2-oxoethyl] ester

2-Methyl-1-phenyl-5-benzimidazolecarboxylic acid [2-(2-methoxyanilino)-2-oxoethyl] ester

C24H21N3O4 (415.1532)


   

1-(1,3-Benzodioxol-5-ylmethyl)-3-hydroxy-3-[2-(4-methylphenyl)-2-oxoethyl]-2-indolone

1-(1,3-Benzodioxol-5-ylmethyl)-3-hydroxy-3-[2-(4-methylphenyl)-2-oxoethyl]-2-indolone

C25H21NO5 (415.142)


   

Ethyl 4-(sec-butyl{[(3,4-dichlorophenyl)amino]carbonyl}amino)piperidine-1-carboxylate

Ethyl 4-(sec-butyl{[(3,4-dichlorophenyl)amino]carbonyl}amino)piperidine-1-carboxylate

C19H27Cl2N3O3 (415.1429)


   
   
   
   
   
   
   
   
   
   
   

BAY-179

BAY-179

C23H21N5OS (415.1467)


BAY-179 is a potent, selective, and species cross-reactive complex I inhibitor (IC50=79 μM)[1].

   

2-({[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-1-methyl-1-oxohydrazinium

2-({[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-1-methyl-1-oxohydrazinium

[C14H27N2O12]+ (415.1564)


   

1-methyl-1-oxo-2-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)hydrazinium

1-methyl-1-oxo-2-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)hydrazinium

[C14H27N2O12]+ (415.1564)


   

(3r,3's)-3'-methoxy-1,3'-dimethyl-2'-[(1e)-2-phenylethenyl]spiro[indole-3,6'-pyrrolo[1,2-c]imidazole]-1',2,5'-trione

(3r,3's)-3'-methoxy-1,3'-dimethyl-2'-[(1e)-2-phenylethenyl]spiro[indole-3,6'-pyrrolo[1,2-c]imidazole]-1',2,5'-trione

C24H21N3O4 (415.1532)


   

3'-methoxy-1,3'-dimethyl-2'-(2-phenylethenyl)spiro[indole-3,6'-pyrrolo[1,2-c]imidazole]-1',2,5'-trione

3'-methoxy-1,3'-dimethyl-2'-(2-phenylethenyl)spiro[indole-3,6'-pyrrolo[1,2-c]imidazole]-1',2,5'-trione

C24H21N3O4 (415.1532)